Detalles de la búsqueda
1.
Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 25(10): 2086-2090, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228584
2.
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups.
Biol Blood Marrow Transplant
; 24(12): 2443-2449, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30142419
3.
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.
Blood
; 128(8): 1050-8, 2016 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297790
4.
Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated.
Haematologica
; 103(10): 1708-1719, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30076185
5.
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Biol Blood Marrow Transplant
; 23(8): 1327-1334, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28461213
6.
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
Biol Blood Marrow Transplant
; 23(5): 767-775, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28115276
7.
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(2): 269-277, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864161
8.
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 23(6): 971-979, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28288952
9.
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
Biol Blood Marrow Transplant
; 22(2): 248-257, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26327629
10.
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
Haematologica
; 101(11): 1426-1433, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27662010
11.
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
Biol Blood Marrow Transplant
; 21(8): 1343-59, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25985921
12.
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 21(6): 1046-1053, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25687795
13.
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.
Biol Blood Marrow Transplant
; 21(1): 165-71, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316111
14.
The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
Biol Blood Marrow Transplant
; 21(7): 1251-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25840335
15.
Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.
Biol Blood Marrow Transplant
; 21(10): 1815-22, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26071866
16.
Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.
Biol Blood Marrow Transplant
; 21(10): 1830-8, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26116089
17.
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
Biol Blood Marrow Transplant
; 21(10): 1776-82, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033280
18.
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.
Biol Blood Marrow Transplant
; 21(10): 1746-53, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25981509
19.
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 21(9): 1605-11, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25983043
20.
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 21(2): 266-74, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445023